Skip to main content
. 2021 Oct 29;2021(10):CD013658. doi: 10.1002/14651858.CD013658.pub2

Gicalone 2015.

Study characteristics
Methods Prospective single‐centre cohort
September 2003 to September 2004
University Hospital of Montpellier, France
99 participants
Participants Inclusion: women with breast cancer whose breast size and/or ptosis, made it possible to consider either conventional surgical treatment or oncoplastic surgery as a first‐line treatment
Exclusion:

  • Inflammatory carcinomas (4)

  • Locally advanced tumours for which neoadjuvant chemotherapy was indicated (15)

  • Tumours requiring an immediate mastectomy (20)

  • Patients with local recurrence after conservative treatment (10)

  • Patients for whom the breast morphology did not allow oncoplastic surgery (9)
Interventions Intervention:

  • VD‐Upper 21

  • Central 13

  • Superomedial 7

  • Inferior and central 1


Control: BCS ‐ WLE
Outcomes Primaryoutcomes:

  • No outcomes of interest


Seondaryoutcomes:

  • Re‐excisions

  • Complications


Other outcomes:

  • Operative time

  • Length of stay
Notes No disclosures/funding declared
Different to Giacalone 2007 (1) and (2) as has different intervention
Translated from French